Intelligence · Clinical Pipeline
R&D Pipeline Programs
ClinicalTrials.gov programs linked to pharma sponsors — phase, modality, and trial IDs for BD and competitive intelligence.
- Programs indexed
- 20,548
- Companies
- 1,769
- Drugs tracked
- 4,797
Quick answer
NovaPharmaNews tracks 20,548 pharmaceutical R&D pipeline programs sourced from ClinicalTrials.gov, linked to sponsor companies. Each profile includes development phase, modality, trial status, NCT identifiers, and indication text — searchable for business development and competitive intelligence.
-
blood sampling (alpha-Galactosidase & LysoGb3)
Takeda
Fabry Disease
1 trial -
cefditoren pivoxil tablets
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Medication Safety
1 trial -
cyclosporine
Ultragenyx UK Limited
Metabolism, Inborn Errors
1 trial -
evolocumab
Beijing Luhe Hospital
STEMI
1 trial -
human cord blood-derived mononuclear cells (HCB-MNCs)
The First People's Hospital of Lianyungang
Refractory Diabetic Foot
1 trial -
insulin aspart
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Type 2 Diabetes Mellitus
1 trial -
insulin injection 15 minutes before meals
The First People's Hospital of Lianyungang
Diabetes
1 trial -
intranasal oxytocin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Learning Disabilities
1 trial -
iodine-containg spareribs soup
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Iodine Bioavailability
1 trial -
multi-factorial intervention
United Therapeutics Europe Ltd
Type 2 Diabetes Mellitus
1 trial -
omega-3 polyunsaturated fatty acids
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Type 2 Diabetes Mellitus
1 trial -
rabeprazole plus aspirin versus rabeprazole plus clopidogrel
Hospital Authority, Hong Kong
Gastric Ulcer
1 trial -
salvianolate injection
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Angina, Stable
1 trial -
the absorbable hemostat and suture
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Ovarian Cyst Benign
1 trial -
the traditional Chinese medicine prescription ' Shenzhuo Decoction '
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Diabetic Kidney Disease (DKD)
1 trial -
the usage of Olverembatinib combined with Inotuzumab Ozogamicin
Xiyuan Hospital of China Academy of Chinese Medical Sciences
Ph+ ALL
1 trial -
zanubrutinib, bendamustine, and obinutuzumab
The First People's Hospital of Lianyungang
Follicular Lymphoma
1 trial
Frequently asked questions
What is the NovaPharmaNews pipeline directory?
It is a searchable index of 20,548 clinical development programs grouped by sponsor company, with phase (Phase 1–3), modality, trial status, and linked NCT IDs from ClinicalTrials.gov.
Where does pipeline data come from?
Program records are derived from ClinicalTrials.gov and linked to NovaPharmaNews company profiles. Trial status and phase reflect registry data at last sync — verify on ClinicalTrials.gov before investment or partnering decisions. See our data sources page for attribution.
How do I find pipeline programs by company or phase?
Use the search box to match program name, indication, company name, or slug. Results are ordered with late-stage (Phase 3) programs first. Open any row to view the full program profile under its sponsor company.
Data attribution and licensing: Data sources